Meningeal spread of leukemia is not infrequent. In particular the triad between CNS, CN and radicular symptoms is characteristic. CH do not necessarily involve the meninges, however proximity of CH to the meninges either intracranially or spinal does not exclude an additional LC. The following considerations focus on CH.
neuropathies, rare isolated effects of chemotherapy, and peripheral nerve tumors, as amyloidomas and rare leukemic deposition have to be considered. This is in particular difficult in cases in remission or after transplantation. In leukemia also coagulopathies can cause focal hemorrhages into peripheral nerves resulting in painful mononeuropathies.
Muscle
Also skeletal muscle can be the site of CHs [30] , Muscle: massteric [6] .
Discussion
The occurrence of a solid mass as presentation of leukemia (CH), is a rare event which can occur as a presentation, during the course of leukemia, as a relapse or as a complication of bone marrow transplant.
Imaging with MR, US and PET [17, 11] , has facilitated the detection, which may point of a more frequent appearance (However precise clinical criteria for the appearance of CH in ultrasound and MR are lacking.
The appearance of leukemia and CH in peripheral nerves is interesting. It has been proposed that the peripheral nerves and the peripheral nerve blood barrier may be an ideal situation to leukemic cells to survive in a sanctuary. However in most cases of leukemia the CN and peripheral nerves are spared from tumor infiltration, except the in intra -meningeal part, where LC is a frequent event. Another interesting aspect is the transformation of a liquid cancer into a solid cancer, at times isolated as a solid cancer, without the liquid presentation.
The appearance of CH is often uncharacteristic, and may require biopsy. Peripheral tumors are rare, the differential diagnostic approach needs to include several other differential diagnosis in particular if the CH is the first manifestation of leukemia. Once leukemia has been diagnosed this is more likely in acute and myeloid leukemia, and it has been described as recurrence or after BMT.
